Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126779283 | 12677928 | 3 | F | 20160730 | 20160906 | 20160823 | 20160913 | EXP | JP-CELGENEUS-JPN-2016085767 | CELGENE | 59.00 | YR | F | Y | 48.00000 | KG | 20160913 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126779283 | 12677928 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | 150 MILLIGRAM | U | 21660 | 150 | MG | INJECTION FOR INFUSION | QOW | |||||
| 126779283 | 12677928 | 2 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | 0 | INJECTION FOR INFUSION | |||||||||
| 126779283 | 12677928 | 3 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | 0 | INJECTION FOR INFUSION | |||||||||
| 126779283 | 12677928 | 4 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | 0 | 700 | MG | INJECTION FOR INFUSION | QOW | ||||||
| 126779283 | 12677928 | 5 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 1500 | MG | UNKNOWN | QD | |||||||
| 126779283 | 12677928 | 6 | C | Loxoprofen sodium hydrate | LOXOPROFEN SODIUM DIHYDRATE | 1 | Oral | 0 | UNKNOWN | QD | |||||||||
| 126779283 | 12677928 | 7 | C | OPIUM TINCTURE | MORPHINE | 1 | Oral | 0 | 1.5 | ML | UNKNOWN | QD | |||||||
| 126779283 | 12677928 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 20 | MG | UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126779283 | 12677928 | 1 | Pancreatic carcinoma metastatic |
| 126779283 | 12677928 | 2 | Pancreatic carcinoma metastatic |
| 126779283 | 12677928 | 5 | Abdominal pain |
| 126779283 | 12677928 | 6 | Product used for unknown indication |
| 126779283 | 12677928 | 7 | Diarrhoea |
| 126779283 | 12677928 | 8 | Ascites |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126779283 | 12677928 | OT |
| 126779283 | 12677928 | LT |
| 126779283 | 12677928 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126779283 | 12677928 | Decreased appetite | |
| 126779283 | 12677928 | Depressed level of consciousness | |
| 126779283 | 12677928 | Disseminated intravascular coagulation | |
| 126779283 | 12677928 | Dysarthria | |
| 126779283 | 12677928 | Myalgia | |
| 126779283 | 12677928 | Neutrophil count decreased | |
| 126779283 | 12677928 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126779283 | 12677928 | 1 | 20160629 | 20160721 | 0 | |
| 126779283 | 12677928 | 2 | 20131128 | 20140807 | 0 | |
| 126779283 | 12677928 | 3 | 20150319 | 20160615 | 0 | |
| 126779283 | 12677928 | 4 | 20160629 | 20160721 | 0 | |
| 126779283 | 12677928 | 5 | 20160706 | 20160731 | 0 | |
| 126779283 | 12677928 | 6 | 20160706 | 20160731 | 0 | |
| 126779283 | 12677928 | 7 | 20150108 | 20160731 | 0 | |
| 126779283 | 12677928 | 8 | 20160526 | 20160731 | 0 |